rdf:type |
|
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0025007,
umls-concept:C0025010,
umls-concept:C0079189,
umls-concept:C0597357,
umls-concept:C0871261,
umls-concept:C0913092,
umls-concept:C1420084,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1882417,
umls-concept:C2911692
|
pubmed:issue |
33
|
pubmed:dateCreated |
2011-7-18
|
pubmed:abstractText |
Despite the use of measles vaccine, measles virus continues to circulate and cause severe disease. Immune responses to the measles vaccine are variable between individuals, with up to 10% failing to produce a sufficient protective response post-vaccination. Signaling lymphocyte activation molecule (SLAM) and dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN; CD209) are specific measles receptors: SLAM binds and permits entry of the virus into the cell, DC-SIGN acts as an attachment receptor, increasing viral binding efficiency and transmission. Genetic variations in these receptor genes may alter measles vaccine antibody and cellular responses.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/CD150 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/DC-specific ICAM-3 grabbing...,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins, C-Type,
http://linkedlifedata.com/resource/pubmed/chemical/Measles Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Virus
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1873-2518
|
pubmed:author |
|
pubmed:copyrightInfo |
Crown Copyright © 2011. Published by Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
26
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5407-13
|
pubmed:meshHeading |
pubmed-meshheading:21645571-Antibodies, Viral,
pubmed-meshheading:21645571-Antigens, CD,
pubmed-meshheading:21645571-Cell Adhesion Molecules,
pubmed-meshheading:21645571-Cytokines,
pubmed-meshheading:21645571-Female,
pubmed-meshheading:21645571-Gene Frequency,
pubmed-meshheading:21645571-Humans,
pubmed-meshheading:21645571-Infant,
pubmed-meshheading:21645571-Lectins, C-Type,
pubmed-meshheading:21645571-Male,
pubmed-meshheading:21645571-Measles Vaccine,
pubmed-meshheading:21645571-Polymorphism, Genetic,
pubmed-meshheading:21645571-Receptors, Cell Surface,
pubmed-meshheading:21645571-Receptors, Virus,
pubmed-meshheading:21645571-Western Australia
|
pubmed:year |
2011
|
pubmed:articleTitle |
SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine.
|
pubmed:affiliation |
School of Paediatrics and Child Health, University of Western Australia, Perth, WA, Australia. holly.clifford@gmail.com
|
pubmed:publicationType |
Journal Article
|